Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ribodoc
    Junior Member
    • Dec 2011
    • 6

    #1

    PacBio RS II SMRTcell performance variability

    We are observing increased variability in the performance of SMRTcells by lot, strip and within a strip. Using the same SMRTbell template on different sequencing runs the variability can be as much as a two fold difference between strips of SMRTcells. We would like advice from other users who may experiencing the same issue.
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #2
    Are you referring to just successful loading? Or some other metrics (RL, accuracy)?

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      @ribodoc: Was there a time when you were regularly getting consistent results and now you are not?

      Comment

      • ribodoc
        Junior Member
        • Dec 2011
        • 6

        #4
        Originally posted by ECO View Post
        Are you referring to just successful loading? Or some other metrics (RL, accuracy)?
        Within a week, with the same SMRTbell template and loading concentration went from 47.44% P1 to 26.64% P1. Accuracy dipped from 0.841 to 0.831. Polymerase read length N50 had a smaller drop from 16285 to 15849.

        Comment

        • ribodoc
          Junior Member
          • Dec 2011
          • 6

          #5
          Originally posted by GenoMax View Post
          @ribodoc: Was there a time when you were regularly getting consistent results and now you are not?
          Occasionally we see this occur and it was time to put it out to the community. We typically do a titration of SMRTbell concentration for loading and then do a production run on a strip of SMRTcells. There will be periods of time when the tritration and production runs are very consistent and then there are other times when they are not consistent and even not consistent within a strip of SMRTcells.

          Comment

          • GenoMax
            Senior Member
            • Feb 2008
            • 7142

            #6
            Originally posted by ribodoc View Post
            Occasionally we see this occur and it was time to put it out to the community. We typically do a titration of SMRTbell concentration for loading and then do a production run on a strip of SMRTcells. There will be periods of time when the tritration and production runs are very consistent and then there are other times when they are not consistent and even not consistent within a strip of SMRTcells.
            That has been more or less the story. While I don't work at the bench I hear similar observations most of the time. There is no logical explanation that can be put forth either. Hopefully Sequel will be more reliable.

            Comment

            • ribodoc
              Junior Member
              • Dec 2011
              • 6

              #7
              Originally posted by GenoMax View Post
              That has been more or less the story. While I don't work at the bench I hear similar observations most of the time. There is no logical explanation that can be put forth either. Hopefully Sequel will be more reliable.
              Thank you for the response.

              Comment

              • ECO
                --Site Admin--
                • Oct 2007
                • 1360

                #8
                @Genomax...the logical explanation is that the SMRTcell production process is dramatically more complicated than all other sequencing consumables, ZMW size and uniformity, the micromirror shape, aluminum coating, then on top of that the blocking of the surface and then the biotinylation.

                I know it's no solace to scientists trying to do reproducible production (we run two RSII's all the time), but it's kind of amazing just how well it all works, and is a testament to all the people that have contributed at PACB. (disclaimer I worked there for a long time and know a lot of people there still)

                Comment

                • GenoMax
                  Senior Member
                  • Feb 2008
                  • 7142

                  #9
                  I have nothing but admiration for the amount of technology that went into making the original PacBio machine, consumables.

                  Based on anecdotal references keeping an RSII running ALL the time seems to be essential for its well being. Sadly we could not do that.

                  Comment

                  • luc
                    Senior Member
                    • Dec 2010
                    • 469

                    #10
                    The SMRT-cell quality (and correlated to it the yields) can indeed be quite variable in general .
                    The very last batches of SMRT-cells seem to be more variable than usual (for us and also some other labs). These higher frequency problems seem to occur at least once a year.

                    Comment

                    Latest Articles

                    Collapse

                    • SEQadmin2
                      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                      by SEQadmin2



                      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                      Despite this, “CRISPR helped turn genome editing from a specialized technique into
                      ...
                      07-31-2026, 11:01 AM
                    • SEQadmin2
                      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                      by SEQadmin2


                      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                      The systematic characterization of the human proteome has
                      ...
                      07-20-2026, 11:48 AM

                    ad_right_rmr

                    Collapse

                    News

                    Collapse

                    Topics Statistics Last Post
                    Started by SEQadmin2, 08-06-2026, 07:41 AM
                    0 responses
                    22 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 08-03-2026, 10:13 AM
                    0 responses
                    33 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-31-2026, 02:55 AM
                    0 responses
                    43 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-24-2026, 12:17 PM
                    0 responses
                    26 views
                    0 reactions
                    Last Post SEQadmin2  
                    Working...